Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Introduce Six GeneChip-Based Diagnostics Within 18 Months

NEW YORK, May 7 - A Roche official said today that the Swiss pharma giant will introduce six new diagnostic products over the next 18 months based on the Affymetrix GeneChip platform it licensed in January.


In a widely reported news conference in Switzerland, Heino von Prondzynski, the head of Roche's diagnostics division identified what tests the company plans to introduce into the market.


Initially, the company will roll out the AmpliChip CYP450 microarray for lab use in the US in May. The chip, designed by Roche and manufactured by Affymetrix, will be sold as an analyte-specific reagent.


Then, the company will also launch Affymetrix platform diagnostic tests for human papilloma virus, cystic fibrosis, colorectal cancer, HIV, and leukemia.


Roche officials were not available for comment.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more